PreludeDx Taps Seasoned Exec MiMi Reyes to Scale Operations Amid Rising Demand
Event summary
- PreludeDx appointed MiMi Reyes as Senior Vice President of Operations on January 22, 2026.
- Reyes brings over 25 years of experience in diagnostics and medical device operations.
- She will oversee laboratory operations to support the company's expansion and new test launches.
- Reyes previously led global operations at MDxHealth and was an early pioneer at Agendia.
The big picture
PreludeDx's appointment of MiMi Reyes underscores its strategic focus on operational excellence to meet rising demand for precision diagnostics. The move comes as the company prepares to launch new tests, positioning itself in a competitive landscape where scalability and regulatory compliance are critical. Reyes' background in managing high-compliance laboratories suggests PreludeDx is prioritizing operational robustness to support its growth initiatives.
What we're watching
- Operational Scaling
- How Reyes' expertise will accelerate PreludeDx's laboratory capacity and automation efforts.
- Market Demand
- Whether the company can sustain its growth trajectory amid increasing patient demand.
- Product Launch
- The pace at which PreludeDx integrates the new AidaBreast invasive breast cancer test into its portfolio.
Our editorial coverage: